RVNC   $5.3  2.32% Market Closed After Close 5.29 -0.19%

Revance Therapeutics Inc
Total Cash 232.24M
totalCashPerShare 2.216
EBITDA -192.06M
Total Debt 491.64M
quickRatio 2.866
currentRatio 3.74
Total Revenue 251.18M
debtToEquity
Revenue/Share 2.72
ROA -0.22774
ROE
grossProfits
freeCashflow -151.11M
operatingCashflow -200.76M
earningsGrowth
revenueGrowth 0.202
grossMargins 0.38444
ebitdaMargins -0.76462996
operatingMargins -0.52786
profitMargins -1.1446099
enterpriseValue 813.91M
forwardPE -8.138462
floatShares 85.38M
sharesOutstanding 104.18M
sharesShort 9.54M
sharesShortPriorMonth 7.56M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.75%
Short Ratio help_outline 1.89%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue -1.238
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -304.34M
trailingEps -3.43%
forwardEps -0.65%
enterpriseToEbitda -4.24
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.38 3Q 2024
institutionsCount 244
lastUpdated Oct. 21, 2024, 1:29 p.m.